• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Survival is not a good outcome for randomized trials with effective subsequent therapies.

作者信息

Buyse Marc, Sargent Daniel J, Saad Everardo D

出版信息

J Clin Oncol. 2011 Dec 10;29(35):4719-20; author reply 4720-1. doi: 10.1200/JCO.2011.38.4206. Epub 2011 Oct 31.

DOI:10.1200/JCO.2011.38.4206
PMID:22042965
Abstract
摘要

相似文献

1
Survival is not a good outcome for randomized trials with effective subsequent therapies.对于有有效后续治疗的随机试验而言，生存并非良好的结果。
J Clin Oncol. 2011 Dec 10;29(35):4719-20; author reply 4720-1. doi: 10.1200/JCO.2011.38.4206. Epub 2011 Oct 31.
2
New challenges for comparative effectiveness in oncology: choice of primary end points for randomized clinical trials.肿瘤学中比较疗效学的新挑战：随机临床试验主要终点的选择。
J Comp Eff Res. 2013 Sep;2(5):469-81. doi: 10.2217/cer.13.50.
3
The challenges of randomized trials in integrative cancer care.综合癌症护理中随机试验的挑战。
Integr Cancer Ther. 2004 Jun;3(2):112-27. doi: 10.1177/1534735404265668.
4
Availability of experimental therapy outside oncology randomized clinical trials in the United States.美国肿瘤学以外的实验疗法在随机临床试验中的可及性。
J Clin Oncol. 2010 Dec 1;28(34):5067-73. doi: 10.1200/JCO.2010.28.6567. Epub 2010 Oct 25.
5
Unconventional therapies and cancer.非常规疗法与癌症。
CMAJ. 1999 Sep 21;161(6):686-7.
6
[Phases 0, 1 and 2 oncology clinical trials: current questions].[肿瘤学0期、1期和2期临床试验：当前问题]
Bull Cancer. 2010 Jan;97(1):55-63. doi: 10.1684/bdc.2010.1016.
7
Commentary: randomized controlled trials.评论：随机对照试验
Surg Oncol Clin N Am. 2010 Jan;19(1):xix-xx. doi: 10.1016/j.soc.2009.09.016.
8
Meta-analysis of randomized control trials applied to cancer therapy.应用于癌症治疗的随机对照试验的荟萃分析。
Important Adv Oncol. 1992:235-41.
9
The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments.
BMJ. 1999 Apr 17;318(7190):1074.
10
Proposal for the use of progression-free survival in unblinded randomized trials.关于在非盲法随机试验中使用无进展生存期的提议。
J Clin Oncol. 2007 May 20;25(15):2122-6. doi: 10.1200/JCO.2006.09.6198.

引用本文的文献

1
Real-World Evidence: Better than Nothing or the Future? A Perspective on Clinical Evidence Generation in Interventional Oncology.真实世界证据：聊胜于无还是未来趋势？介入肿瘤学临床证据生成的视角
Cardiovasc Intervent Radiol. 2025 Sep 25. doi: 10.1007/s00270-025-04179-4.
2
Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.晚期/转移性疾病 III 期试验次要总生存终点的时间和报告。
J Clin Oncol. 2023 Oct 10;41(29):4616-4620. doi: 10.1200/JCO.23.00413. Epub 2023 Jul 20.
3
Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial.
动脉内注射TheraSphere钇-90玻璃微球治疗不可切除肝细胞癌患者：STOP-HCC 3期随机对照试验方案
JMIR Res Protoc. 2018 Aug 15;7(8):e11234. doi: 10.2196/11234.
4
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.自体移植后2年的无进展生存期：滤泡性淋巴瘤总生存期的替代终点
Cancer Med. 2017 Dec;6(12):2766-2774. doi: 10.1002/cam4.1217. Epub 2017 Oct 26.
5
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.与肝动脉化疗栓塞术相比，钇-90放射性栓塞术显著延长了肝细胞癌患者的疾病进展时间。
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
6
Kernel machine score test for pathway analysis in the presence of semi-competing risks.核机器评分检验在存在半竞争风险下的通路分析。
Stat Methods Med Res. 2018 Apr;27(4):1099-1114. doi: 10.1177/0962280216653427. Epub 2016 Jun 2.
7
Interpreting overall survival results when progression-free survival benefits exist in today's oncology landscape: a metastatic renal cell carcinoma case study.在当今肿瘤学领域存在无进展生存期获益的情况下解读总生存期结果：转移性肾细胞癌病例研究。
Cancer Manag Res. 2014 Sep 22;6:365-71. doi: 10.2147/CMAR.S67249. eCollection 2014.
8
Measures of outcome in metastatic breast cancer: insights from a real-world scenario.转移性乳腺癌的结局指标：来自真实世界的见解。
Oncologist. 2014 Jun;19(6):608-15. doi: 10.1634/theoncologist.2014-0002. Epub 2014 May 2.
9
Cancer concepts and principles: primer for the interventional oncologist-part I.癌症概念和原则：介入肿瘤学家入门-第一部分。
J Vasc Interv Radiol. 2013 Aug;24(8):1157-64. doi: 10.1016/j.jvir.2013.04.024. Epub 2013 Jun 25.
10
Methodological assessment of HCC literature.肝癌文献的方法学评估。
Ann Oncol. 2013 Apr;24 Suppl 2(Suppl 2):ii6-14. doi: 10.1093/annonc/mdt052.